The MANTRA Trial (MANdibular TRauma and Antibiotic Use)

PHASE3RecruitingINTERVENTIONAL
Enrollment

2,841

Participants

Timeline

Start Date

December 6, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Mandible FracturePost-operative Antibiotics
Interventions
DRUG

Different post-operative antibiotic regimens following surgical treatment of mandible fractures

"The 3 study arms represent the most common antibiotic regimens used in current clinical practice following surgery for mandible fractures. The control group is the most common approach.~All patients will receive 1 dose of IV antibiotics (co-amoxiclav 1.2g), if no penicillin allergy, on induction of anaesthesia, prior to their surgery.~The participants will be randomised to the following (1:1:1):~Group A: No further antibiotics Group B: 2 further postoperative IV doses of co-amoxiclav 1.2g Group C: 2 further postoperative IV doses (as above), followed by a 5-day course of oral co-amoxiclav 625mg every 8 hours if no penicillin allergy (Control)."

Trial Locations (2)

BB2 3HH

RECRUITING

East Lancashire Hospitals NHS Trust, Blackburn

NOT_YET_RECRUITING

East Lancashire Hospitals NHS Trust, Blackburn

All Listed Sponsors
lead

East Lancashire Hospitals NHS Trust

OTHER

NCT05964140 - The MANTRA Trial (MANdibular TRauma and Antibiotic Use) | Biotech Hunter | Biotech Hunter